Journal of International Oncology ›› 2020, Vol. 47 ›› Issue (3): 174-179.doi: 10.3760/cma.j.issn.1673-422X.2020.03.009
• Review • Previous Articles Next Articles
Peng Caiyun, Han Chun(), Wang Lan
Received:
2019-10-14
Revised:
2020-01-20
Online:
2020-03-08
Published:
2020-05-27
Contact:
Han Chun
E-mail:hanchun2006@126.com
Peng Caiyun, Han Chun, Wang Lan. Advances in radiation of internal mammary lymph nodes after breast-conserving or modified radical surgery for breast cancer[J]. Journal of International Oncology, 2020, 47(3): 174-179.
[1] |
Darby S, McGale P, Correa C , et al. Effect of radiotherapy after breast conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials[J]. Lancet, 2011,378(9804):1707-1716. DOI: 10.1016/S0140-6736(11)61629-2.
doi: 10.1016/S0140-6736(11)61629-2 |
[2] |
Sedlmayer F, Sautter Bihl ML, Budach W , et al. DEGRO practical guidelines: radiotherapy of breast cancer Ⅰ: radiotherapy following breast conserving therapy for invasive breast cancer[J]. Strahlenther Onkol, 2013,189(10):825-833. DOI: 10.1007/s00066-013-0437-8.
doi: 10.1007/s00066-013-0437-8 |
[3] |
Cong BB, Cao XS, Cao L , et al. Internal mammary lymph nodes radiotherapy of breast cancer in the era of individualized medicine[J]. Oncotarget, 2017,8(46):81583-81590. DOI: 10.18632/oncotarget.20186.
doi: 10.18632/oncotarget.v8i46 |
[4] | Grantzau T, Overgaard J . Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients[J]. Radiother Oncol, 2015,114(1):56-65. DOI: 10.1016/j.radonc.2014.10.004. |
[5] |
Chen RC, Lin NU, Golshan M , et al. Internal mammary nodes in breast cancer: diagnosis and implications for patient management a systematic review[J]. J Clin Oncol, 2008,26(30):4981-4989. DOI: 10.1200/JCO.2008.17.4862.
doi: 10.1200/JCO.2008.17.4862 |
[6] |
Ferreres García K, Siegrist Ridruejo J, Rincón Olbés P , et al. Therapeutic attitude towards internal mammary chain drainage in patients with breast cancer[J]. Breast, 2016,30:1-4. DOI: 10.1016/j.breast.2016.08.001.
doi: 10.1016/j.breast.2016.08.001 |
[7] |
Chang JS, Park W, Kim YB , et al. Longterm survival outcomes following internal mammary node irradiation in stage Ⅱ-Ⅲ breast cancer: results of a large retrospective study with 12 year follow up[J]. Int J Radiat Oncol Biol Phys, 2013,86(5):867-872. DOI: 10.1016/j.ijrobp.2013.02.037.
doi: 10.1016/j.ijrobp.2013.02.037 |
[8] |
Recht A, Comen EA, Fine RE , et al. Postmastectomy radiotherapy: an american society of clinical oncology, american society for radiation oncology, and society of surgical oncology focused guideline update[J]. J Clin Oncol, 2016,34(36):4431-4442. DOI: 10.1016/j.prro.2016.08.009.
doi: 10.1200/JCO.2016.69.1188 |
[9] | 中国抗癌学会乳腺癌专业委员. 中国抗癌协会乳腺癌诊治指南与规范(2017年版)[J]. 中国癌症杂志, 2017,27(9):695-759. DOI: 10.19401/j.cnki.1007-3639.2017.09.004. |
[10] |
Coates AS, Winer EP, Goldhirsch A , et al. Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015[J]. Ann Oncol, 2015,26(8):1533-1546. DOI: 10.1093/annonc/mdv221.
doi: 10.1093/annonc/mdv221 |
[11] |
Recht A, Gray R, Davidson NE , et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooerative Oncology Group[J]. J Clin Oncol, 1999,17(6):1689-1700. DOI: 10.1200/JCO.1999.17.6.1689.
doi: 10.1200/JCO.1999.17.6.1689 |
[12] |
Qi XW, Du JZ, Tang P , et al. Clinical significance of internal mammary lymph node metastasis for breast cancer: analysis of 337 breast cancer patients[J]. Surg Oncol, 2018,27(2):185-191. DOI: 10.1016/j.suronc.2018.03.006.
doi: 10.1016/j.suronc.2018.03.006 |
[13] |
Jethwa KR, Kahila MM, Hunt KN , et al. Delineation of internal mammary nodal target volumes in breast cancer radiation therapy[J]. Int J Radiat Oncol Biol Phys, 2017,97(4):762-789. DOI: 10.1016/j.ijrobp.2016.11.037.
doi: 10.1016/j.ijrobp.2016.11.037 |
[14] |
Huang O, Wang L, Shen K , et al. Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy[J]. Breast Cancer Res Treat, 2008,107(3):379-387. DOI: 10.1007/s10549-007-9561-4.
doi: 10.1007/s10549-007-9561-4 |
[15] |
Whelan TJ, Olivotto IA, Parulekar WR , et al. Regional nodal irradiation in early-stage breast cancer[J]. N Engl J Med, 2015,373(4):307-316. DOI: 10.1056/NEJMoa1415340.
doi: 10.1056/NEJMoa1415340 |
[16] |
Poortmans PM, Collette S, Kirkove C , et al. Internal mammary and medial supraclavicular irradiation in breast cancer[J]. N Engl J Med, 2015,373(4):317-327. DOI: 10.1056/NEJMoa1415369.
doi: 10.1056/NEJMoa1415369 |
[17] |
McGale P, Taylor C, Correa C , et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials[J]. Lancet, 2014,383(9935):2127-2135. DOI: 10.1016/S0140-6736(14)60488-8.
doi: 10.1016/S0140-6736(14)60488-8 |
[18] | Thorsen LB, Offersen BV, Danø H , et al. DBCG-IMN: a population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer[J]. J Clin Oncol, 2016,34(4):314-320. DOI: 10.1200/JCO.2015.63.6456. |
[19] |
Luo J, Jin K, Chen X , et al. Internal mammary node irradiation (IMNI) improves survival outcome for patients with clinical stage Ⅱ-Ⅲ breast cancer after preoperative systemic therapy[J]. Int J Radiat Oncol Biol Phys, 2019,103(4):895-904. DOI: 10.1016/j.ijrobp.2018.11.003.
doi: 10.1016/j.ijrobp.2018.11.003 |
[20] |
Hennequin C, Bossard N, Servagi Vernat S , et al. Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy[J]. Int J Radiat Oncol Biol Phys, 2013,86(5):860-866. DOI: 10.1016/j.ijrobp.2013.03.021.
doi: 10.1016/j.ijrobp.2013.03.021 |
[21] |
Freedman GM, Fowble BL, Nicolaou N , et al. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist?[J]. Int J Radiat Oncol Biol Phys, 2000,46(4):805-814. DOI: 10.1016/s0360-3016(99)00481-2.
doi: 10.1016/S0360-3016(99)00481-2 |
[22] |
Fowble B, Hanlon A, Freedman G , et al. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage Ⅰ and Ⅱ breast cancer[J]. Int J Radiat Oncol Biol Phys, 2000,47(4):883-894. DOI: 10.1016/s0360-3016(00)00526-5.
doi: 10.1016/S0360-3016(00)00526-5 |
[23] |
Olson RA, Woods R, Speers C , et al. Does the intent to irradiate the internal mammary nodes impact survival in women with breast cancer? A population-based analysis in British Columbia[J]. Int J Radiat Oncol Biol Phys, 2012,83(1):e35-e41. DOI: 10.1016/j.ijrobp.2011.11.066.
doi: 10.1016/j.ijrobp.2011.11.066 |
[24] |
Darby SC, Ewertz M, McGale P , et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer[J]. N Engl J Med, 2013,368(11):987-998. DOI: 10.1056/NEJMoa1209825.
doi: 10.1056/NEJMoa1209825 |
[25] |
Hooning MJ, Botma A, Aleman BM , et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer[J]. J Natl Cancer Inst, 2007,99(5):365-375. DOI: 10.1093/jnci/djk064.
doi: 10.1093/jnci/djk064 |
[26] |
Taylor C, Correa C, Duane FK , et al. Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials[J]. J Clin Oncol, 2017,35(15):1641-1649. DOI: 10.1200/JCO.2016.72.0722.
doi: 10.1200/JCO.2016.72.0722 |
[27] |
Nilsson G, Holmberg L, Garmo H , et al. Radiation to supraclavicular and internal mammary lymph nodes in breast cancer increases the risk of stroke[J]. Br J Cancer, 2009,100(5):811-816. DOI: 10.1038/sj.bjc.6604902.
doi: 10.1038/sj.bjc.6604902 |
[28] |
Ma J, Li J, Xie J , et al. Post mastectomy linac IMRT irradiation of chest wall and regional nodes: dosimetry data and acute toxicities[J]. Radiat Oncol, 2013,8:81. DOI: 10.1186/1748-717X-8-81.
doi: 10.1186/1748-717X-8-81 |
[29] |
MacDonald SM, Jimenez R, Paetzold P , et al. Proton radiotherapy for chest wall and regional lymphatic radiation; dose comparisons and treatment delivery[J]. Radiat Oncol, 2013,8:71. DOI: 10.1186/1748-717X-8-71.
doi: 10.1186/1748-717X-8-71 |
[30] |
Yu J, Li G, Li J , et al. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields[J]. Int J Radiat Oncol Biol Phys, 2005,61(3):874-878. DOI: 10.1016/j.ijrobp.2004.06.252.
doi: 10.1016/j.ijrobp.2004.06.252 |
[31] |
Brenner DJ, Shuryak I, Jozef G , et al. Risk and risk reduction of major coronory events associated with contemporary breast radiotherapy[J]. JAMA Intern Med, 2014,174:158-160. DOI: 10.1001/jamainternmed.2013.11790.
doi: 10.1001/jamainternmed.2013.11790 |
[1] | Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei. Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma: a real-world clinical study [J]. Journal of International Oncology, 2024, 51(6): 326-331. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[4] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[5] | Sa Qiang, Xu Hangcheng, Wang Jiayu. Advances in immunotherapy for breast cancer [J]. Journal of International Oncology, 2024, 51(4): 227-234. |
[6] | Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong. Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer [J]. Journal of International Oncology, 2024, 51(4): 235-238. |
[7] | Qian Xiaotao, Shi Ziyi, Hu Ge. A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2024, 51(3): 151-156. |
[8] | Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing. Progress of radiotherapy in oligometastatic non-small cell lung cancer [J]. Journal of International Oncology, 2024, 51(3): 170-174. |
[9] | Chen Boguang, Wang Sugui, Zhang Yongjie. Role of serum cholinesterase and inflammatory markers in the prognosis of stage ⅠA -ⅢA breast cancer [J]. Journal of International Oncology, 2024, 51(2): 73-82. |
[10] | Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei. Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients [J]. Journal of International Oncology, 2024, 51(1): 37-42. |
[11] | Gu Huayan, Zhu Teng, Guo Guilong. Breast microbiota and breast cancer: present and future [J]. Journal of International Oncology, 2024, 51(1): 55-58. |
[12] | Wang Jing, Xu Wenting. Value of NLR, CEA combined with coagulation indicators in the differential diagnosis of benign and malignant breast nodules with a diameter ≤ 1.0 cm [J]. Journal of International Oncology, 2023, 50(9): 520-526. |
[13] | Feng Chengtian, Huang Furong, Cao Shiyu, Wang Jianyu, Nanding Abiyasi, Jiang Yongdong, Zhu Juanying. Relationships between HER2 protein expression and imaging features in HER2 positive breast cancer patients [J]. Journal of International Oncology, 2023, 50(9): 527-531. |
[14] | Cui Tenglu, Lyu lu, Sun Pengfei. Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma [J]. Journal of International Oncology, 2023, 50(9): 548-552. |
[15] | Feng Dongxu, Wu Wei, Gao Pingfa, Wang Jun, Shi Lijuan, Chen Dawei, Li Wenbing, Zhang Meifeng. Effects of miR-451 on glycolysis and apoptosis of breast cancer cells by regulating Rho/ROCK1 pathway [J]. Journal of International Oncology, 2023, 50(8): 449-456. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||